Equities

Fukuda Denshi Co Ltd

6960:TYO

Fukuda Denshi Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)6,610.00
  • Today's Change-70.00 / -1.05%
  • Shares traded27.00k
  • 1 Year change+48.37%
  • Beta0.2646
Data delayed at least 20 minutes, as of May 07 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.

  • Revenue in JPY (TTM)140.43bn
  • Net income in JPY19.31bn
  • Incorporated1948
  • Employees3.38k
  • Location
    Fukuda Denshi Co Ltd2-35-8, HongoBUNKYO-KU 113-8420JapanJPN
  • Phone+81 356841455
  • Fax+81 338141222
  • Websitehttps://www.fukuda.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shofu Inc33.34bn3.09bn57.98bn1.30k18.711.4913.781.74173.13173.131,868.992,177.510.75321.469.4225,665,130.007.025.327.846.0459.7257.269.336.902.87--0.009332.3512.585.6823.1329.0218.3121.16
Tokai Corp (Gifu)136.16bn5.83bn75.92bn4.09k12.790.88787.300.5576165.66165.663,866.942,385.551.2216.396.7333,273,700.005.265.576.757.2924.5124.814.324.592.21--0.020624.615.433.545.171.8610.4314.87
Japan Lifeline Co., Ltd.51.38bn7.52bn94.77bn1.17k12.691.6110.551.8498.5598.55675.02775.420.69371.443.88--10.158.6312.5710.8860.3057.2814.6312.281.96--0.071743.63-0.70732.459.06-0.54465.407.69
HOGY MEDICAL CO., LTD.39.10bn2.80bn95.47bn1.44k32.711.0710.162.44115.55115.551,611.173,547.480.38672.844.99--2.764.243.064.6733.4139.767.1411.584.07--0.061842.570.30531.30-35.03-14.247.944.56
Menicon Co Ltd115.13bn5.10bn114.45bn4.06k24.121.428.880.994161.9261.921,393.251,052.590.713.128.4828,385,600.003.145.123.656.4152.0653.074.435.943.0817.190.469524.7210.007.5213.8322.6621.9514.87
PHC Holdings Corp348.01bn-17.78bn146.82bn9.40k--1.1715.630.4219-141.63-141.632,768.00989.950.62663.485.2737,010,950.00-3.21---4.22--45.43---5.12--0.8877-0.41170.6975--4.69--61.91------
Paramount Bed Holdings Co Ltd100.96bn9.14bn163.40bn3.95k16.871.168.731.62156.82156.821,731.852,284.020.59684.384.4825,584,390.005.405.336.196.3048.0046.449.069.263.82--0.040938.339.585.101.351.9511.415.57
Mani Inc26.37bn6.58bn198.63bn3.69k27.793.5422.937.5366.8266.82267.74523.800.49331.5212.007,156,310.0012.3111.4413.2112.3164.2263.2824.9626.117.32--0.00151.2519.954.0312.539.5624.1220.11
Nipro Corp578.03bn10.24bn216.64bn38.77k23.410.84673.220.374853.9753.973,232.301,492.320.53491.863.3314,909,290.001.050.82751.611.2630.0330.301.971.540.8539--0.689560.4310.196.64-66.01-17.316.34-5.05
NAKANISHI INC.59.69bn22.84bn226.45bn2.05k9.061.838.603.79267.42267.42698.691,327.050.49061.168.4329,132,440.0018.7712.7121.5514.0260.5261.4138.2626.602.05--0.093428.1222.6410.3183.1024.6511.2812.30
Ship Healthcare Holdings Inc618.22bn11.84bn239.02bn8.05k20.041.6712.340.3866117.30117.306,087.681,408.211.6717.655.2376,835,940.003.153.686.586.8410.3810.551.882.361.18--0.288831.0511.266.10-0.89553.11-7.865.59
Fukuda Denshi Co Ltd140.43bn19.31bn250.78bn3.38k10.471.178.691.79638.29638.294,642.155,726.010.69193.304.0841,521,290.009.517.5011.269.6053.6145.2713.759.963.31--0.010328.851.930.8796.5513.1410.8814.87
NIHON KOHDEN CORPORATION218.22bn16.18bn383.36bn5.75k22.602.1319.211.76192.27192.272,593.612,037.861.031.743.8737,943,840.007.678.609.5711.5350.7450.517.418.192.53--0.002626.850.71863.46-26.9913.3320.0211.75
Data as of May 07 2024. Currency figures normalised to Fukuda Denshi Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.06%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Mar 20241.76m4.67%
MFS International Singapore Pte. Ltd.as of 31 Mar 2024573.40k1.52%
The Vanguard Group, Inc.as of 05 Apr 2024497.60k1.32%
Morant Wright Management Ltd.as of 31 Mar 2024441.60k1.17%
Dimensional Fund Advisors LPas of 04 Apr 2024246.50k0.65%
Fidelity Investments Canada ULCas of 31 Mar 202498.80k0.26%
BlackRock Fund Advisorsas of 04 Apr 202462.00k0.16%
Goldman Sachs Asset Management LPas of 29 Feb 202447.20k0.13%
Nomura Asset Management Co., Ltd.as of 29 Dec 202336.70k0.10%
Charles Schwab Investment Management, Inc.as of 04 Apr 202431.15k0.08%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.